# The FDA has reported 162 deaths linked to Ozempic and other diabetes-weight loss drugs. # Deaths were associated with cardiovascular events, diabetic ketoacidosis, and renal failure. # FDA is evaluating the risks and benefits of these medications. ## h2 ## The Food and Drug Administration (FDA) has recently released data linking 162 deaths to Ozempic and other diabetes-weight loss drugs. These deaths have been associated with various health issues such as cardiovascular events, diabetic ketoacidosis, and renal failure. The FDA is currently evaluating the risks and benefits of these medications to ensure patient safety. ## h3 ## It is crucial for individuals considering diabetes-weight loss drugs to discuss the potential risks with their healthcare providers. While these medications may offer benefits in terms of weight loss and blood sugar control, it is essential to be aware of any potential side effects. By staying informed and working closely with healthcare professionals, patients can make informed decisions about their treatment options. Weight Loss Disclaimer: Mindful Evolution offers telehealth services in the states of Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, New York, South Carolina, Tennessee, Texas, and Virginia. For personalized guidance and support on your weight loss journey, contact Mindful Evolution on our website https://yourmindfulevolution.com or call or text us at 954-639-9960.